this has been presented as goodwill impairment , a separate line item in the consolidated statements of income ( loss ) . refer to note 7 - goodwill and intangible assets , net in the consolidated financial statements for additional information . our annual test relies upon key assumptions about revenue and profitability , including the impact of significant planned cost reductions from our strategic transformation program . as with any forecast , there is an element of uncertainty and management has considered this when performing the annual impairment test . key assumptions like the discount rate we use to calculate the present value of the forecasted cash flows for each reporting unit were risk adjusted to reflect these uncertainties . if our actual operating results do not achieve the risk-adjusted forecast of revenue and profitability , or delays in achieving the benefits from the cost reductions assumed in our strategic transformation program occur , there is the risk of future goodwill impairments . as a result of the significant impact of the goodwill impairment charge on our reported revenues , earnings and key metrics for the period , we also discuss our results excluding the impact of this charge . the adjusted results are noted as “ adjusted ” in the discussion below . refer to the “ non-gaap financial measures ” section for a reconciliation and explanation of these non-gaap financial measures . ny mmis charge in february 2017 , we determined that it is probable that we will not fully complete our new york medicaid management information system ( `` ny mmis `` ) project in its current form . as a result of this decision and the application of percentage-of-completion accounting , we recorded a pre-tax charge ( ny mmis charge ) of $ 161 million ( $ 98 million after-tax ) during the fourth quarter of 2016. the charge included $ 83 million for the write-off of contract receivables , which were recorded as a reduction in revenues . in addition , in cost of outsourcing , we recorded a $ 78 million charge which included : $ 36 million for wind-down costs , $ 28 million related to the non-cash impairment of the health enterprise software and $ 14 million for the write-off of deferred contract set-up and transition costs and other related assets and liabilities . at this time , we believe we have recorded our best estimate of the financial statement impact associated with the ny mmis contract developments ; however , our estimate of the financial statement impact is subject to change once the matter is settled with the state of new york . as a result of the significant impact of the ny mmis charge on our reported revenues , earnings and key metrics for the period , we also discuss our results excluding the impact of these charges . these adjusted results are noted as “ adjusted ” in the discussion below . refer to the “ non-gaap financial measures ” section for a reconciliation and explanation of these non-gaap financial measures . significant 2015 charges health enterprise charge late in the third quarter of 2015 , we determined that we would not fully complete the health enterprise medicaid platform implementation projects in california and montana . however , we would continue to process medicaid claims using existing legacy systems in those states , thus providing uninterrupted service for the states ' healthcare providers and constituents . conduent inc. 2016 annual report 25 this determination resulted in recording a pre-tax charge ( he charge ) of $ 389 million ( $ 237 million after-tax ) in 2015. the charge included $ 116 million for the write-off of contract receivables ( primarily non-current ) , $ 34 million related to the non-cash impairment of the he software and deferred contract set-up transition costs and $ 23 million for other related assets and liabilities . the remainder of the charge was primarily related to settlement costs including payments to subcontractors resulting in cash outflows in future quarters . of the $ 389 million charge , $ 116 million was recorded as a reduction to revenues and the remaining $ 273 million was recorded to cost of outsourcing . this development followed the government healthcare strategy change announced in july 2015 , regarding our decision to focus our future he implementations on current medicaid customers and to discontinue investment in and sales of the xerox integrated eligibility system . this change in strategy resulted in pre-tax non-cash software platform impairment charges of $ 146 million ( $ 89 million after-tax ) in the second quarter 2015. as a result of the significant impact of the he charge and the software impairment charges on our reported revenues , earnings and key metrics for the period , we are also discussing our results excluding the impact of these charges . these adjusted results are noted as “ adjusted ” in the discussion below . refer to the `` non-gaap financial measures `` section for a reconciliation and explanation of these non-gaap financial measures . divestitures in december 2014 , we announced an agreement to sell our information technology outsourcing ( ito ) business to atos se and began reporting it as a discontinued operation . the sale was completed on june 30 , 2015. refer to note 4 - divestitures in our consolidated financial statements for additional information . financial overview total revenues of $ 6.4 billion for the year ended december 31 , 2016 , decreased 4 % , with a 1-percentage point negative impact from currency , as compared to 2015. on an adjusted 1 basis , excluding the ny mmis charge , total revenues decreased 4 % with a 1-percentage point negative impact from currency , resulting from declines in commercial industries and healthcare . story_separator_special_tag these valuation approaches require significant judgment and consider a number of factors that include , but are not limited to , expected future cash flows , growth rates and discount rates and comparable multiples from publicly traded companies in our industry . in addition , we are required to make certain assumptions and estimates regarding the current economic environment , industry factors and the future profitability of our businesses . when performing our discounted cash flow analysis for each reporting unit , we incorporate the use of projected financial information and discount rates that are developed using market participant-based assumptions . the cash-flow projections are based on three-year financial forecasts developed by management that include revenue and expense projections , restructuring and strategic transformation activities , capital spending trends and investment in working capital to support anticipated revenue growth or other changes in the business . the selected discount rates consider the risk and nature of the respective reporting units ' cash flows , appropriate capital structure and rates of return that market participants would require to invest their capital in our reporting units . we believe these assumptions are appropriate and reflect our forecasted long-term business model and give appropriate consideration to our historical results as well as the current economic environment and markets that we serve . the average discount rate applied to our projected cash flows for our commercial industries reporting unit was approximately 16 % and 9.5 % was used for both the public sector and healthcare reporting units , which we considered reasonable based on the estimated capital costs of applicable market participants . our impairment assessment methodology includes the use of outside valuation experts and the inclusion of factors and assumptions related to third-party market participants . when performing our market approach for each reporting unit , we rely specifically on the guideline public company method . our guideline public company method incorporates revenues and earnings multiples from publicly traded companies with operations and other characteristics similar to each reporting unit . the selected multiples consider each reporting unit 's relative growth , profitability , size and risk relative to the selected publicly traded companies . after completing our annual impairment review for each reporting unit in the fourth quarter of 2016 , based on our quantitative assessments , we concluded that the fair value of our commercial industries reporting unit was less than its carrying value by approximately 53 % , indicating an impairment . accordingly , we preformed the next step based on step 2 of the impairment assessment process , which resulted in our recording a pre-tax goodwill impairment charge of $ 935 during the fourth quarter of 2016 , which is separately presented in the consolidated statements of income ( loss ) . our healthcare and public sector reporting units passed step 1 of the impairment test with fair value exceeded carrying value by approximately 19 % and 14 % , respectively . refer to note 7 - goodwill and intangible assets , net in the consolidated financial statements for additional information regarding goodwill by reportable segment and the 2016 goodwill impairment charge . conduent inc. 2016 annual report 30 restructuring and asset impairments we have engaged in restructuring actions , which require management to estimate the timing and amount of severance and other employee separation costs for workforce reduction , the fair value of assets made redundant or obsolete and the fair value of lease cancellation and other exit costs . we accrue for severance and other employee separation costs under these actions when it is probable that benefits will be paid and the amount is reasonably estimable . the rates used in determining severance accruals are based on existing plans , historical experiences and negotiated settlements . for a full description of our restructuring actions , refer to our discussions of restructuring in the md & a and in note 8—restructuring programs and asset impairment charges in the consolidated financial statements . income taxes we are subject to income taxes in the united states and numerous foreign jurisdictions . the determination of our provision for income taxes requires significant judgment , the use of estimates and the interpretation and application of complex tax laws . our provision is based on nonrecurring events as well as recurring factors , including the taxation of foreign income . in addition , our provision will change based on discrete or other nonrecurring events such as audit settlements , tax law changes , changes in valuation allowances , and etc . , that may not be predictable . in the event that there is a significant unusual or one-time item recognized in our operating results , the taxes attributable to that item would be separately calculated and recorded at the same time as an unusual or one-time item . we record the estimated future tax effects of temporary differences between the tax bases of assets and liabilities and amounts reported in our consolidated balance sheets , as well as operating loss and tax credit carryforwards . we follow very specific and detailed guidelines in each tax jurisdiction regarding the recoverability of any tax assets recorded in our consolidated balance sheets and provide valuation allowances as required . we regularly review our deferred tax assets for recoverability considering historical profitability , projected future taxable income , the expected timing of the reversals of existing temporary differences and tax planning strategies . gross deferred tax assets of $ 360 million and $ 414 million had valuation allowances of $ 24 million and $ 38 million at december 31 , 2016 and 2015 , respectively . we are subject to ongoing tax examinations and assessments in various jurisdictions . accordingly , we may incur additional tax expense based upon our assessment of the more-likely-than-not outcomes of such matters . in addition , when applicable , we adjust previously recorded tax expense to reflect examination results . our ongoing assessments of the more-likely-than-not outcomes of examinations and

cash flows from investing activities net cash provided by investing activities was $ 16 million for the year ended december 31 , 2016 . the $ 506 million decrease in cash from 2015 was primarily due to the following : $ 992 million decrease in proceeds from sales of businesses . the first twelve months of 2016 included a $ 52 million payment to atos for final post-closing adjustments associated with the 2015 ito divestiture . 2015 included $ 939 million of net proceeds from the sale of the ito business . $ 3 million increase due to lower capital expenditures ( including internal use software ) . $ 196 million increase due to lower acquisitions . $ 285 million increase in net payments on related party notes receivable . $ 11 million increase due to payment received on deferred comp investments . net cash provided by investing activities was $ 522 million for the year ended december 31 , 2015. the $ 1,010 million increase in cash from 2014 was primarily due to the following : $ 923 million increase in net proceeds from the sale of businesses , primarily the ito business . refer to note - 4 divestitures , in the consolidated financial statements for additional information . $ 109 million change from acquisitions . 2015 acquisitions include rsa medical llc for $ 141 million , intellinex llc for $ 28 million , inventive patient access solutions for $ 15 million and healthy communities institute corporation for $ 13 million . 2014 acquisitions include isg holdings , inc. for $ 225 million , invoco holding gmbh for $ 54 million , consilience software , inc. for $ 25 million . $ 31 million due to lower capital expenditures ( including internal use software ) partly due to the sale of the ito business . $ 59 million charge due to higher net payments on related party notes receivable .


 Write a concise suspicious activity report of the following text delimited by triple backquotes. Return your response as a formal report which covers the key points highlighting the location,dates,entity names and account holder information in chronological order of the text.
     ```cash flows from investing activities net cash provided by investing activities was $ 16 million for the year ended december 31 , 2016 . the $ 506 million decrease in cash from 2015 was primarily due to the following : $ 992 million decrease in proceeds from sales of businesses . the first twelve months of 2016 included a $ 52 million payment to atos for final post-closing adjustments associated with the 2015 ito divestiture . 2015 included $ 939 million of net proceeds from the sale of the ito business . $ 3 million increase due to lower capital expenditures ( including internal use software ) . $ 196 million increase due to lower acquisitions . $ 285 million increase in net payments on related party notes receivable . $ 11 million increase due to payment received on deferred comp investments . net cash provided by investing activities was $ 522 million for the year ended december 31 , 2015. the $ 1,010 million increase in cash from 2014 was primarily due to the following : $ 923 million increase in net proceeds from the sale of businesses , primarily the ito business . refer to note - 4 divestitures , in the consolidated financial statements for additional information . $ 109 million change from acquisitions . 2015 acquisitions include rsa medical llc for $ 141 million , intellinex llc for $ 28 million , inventive patient access solutions for $ 15 million and healthy communities institute corporation for $ 13 million . 2014 acquisitions include isg holdings , inc. for $ 225 million , invoco holding gmbh for $ 54 million , consilience software , inc. for $ 25 million . $ 31 million due to lower capital expenditures ( including internal use software ) partly due to the sale of the ito business . $ 59 million charge due to higher net payments on related party notes receivable .
```    
 Suspicious Activity Report : this has been presented as goodwill impairment , a separate line item in the consolidated statements of income ( loss ) . refer to note 7 - goodwill and intangible assets , net in the consolidated financial statements for additional information . our annual test relies upon key assumptions about revenue and profitability , including the impact of significant planned cost reductions from our strategic transformation program . as with any forecast , there is an element of uncertainty and management has considered this when performing the annual impairment test . key assumptions like the discount rate we use to calculate the present value of the forecasted cash flows for each reporting unit were risk adjusted to reflect these uncertainties . if our actual operating results do not achieve the risk-adjusted forecast of revenue and profitability , or delays in achieving the benefits from the cost reductions assumed in our strategic transformation program occur , there is the risk of future goodwill impairments . as a result of the significant impact of the goodwill impairment charge on our reported revenues , earnings and key metrics for the period , we also discuss our results excluding the impact of this charge . the adjusted results are noted as “ adjusted ” in the discussion below . refer to the “ non-gaap financial measures ” section for a reconciliation and explanation of these non-gaap financial measures . ny mmis charge in february 2017 , we determined that it is probable that we will not fully complete our new york medicaid management information system ( `` ny mmis `` ) project in its current form . as a result of this decision and the application of percentage-of-completion accounting , we recorded a pre-tax charge ( ny mmis charge ) of $ 161 million ( $ 98 million after-tax ) during the fourth quarter of 2016. the charge included $ 83 million for the write-off of contract receivables , which were recorded as a reduction in revenues . in addition , in cost of outsourcing , we recorded a $ 78 million charge which included : $ 36 million for wind-down costs , $ 28 million related to the non-cash impairment of the health enterprise software and $ 14 million for the write-off of deferred contract set-up and transition costs and other related assets and liabilities . at this time , we believe we have recorded our best estimate of the financial statement impact associated with the ny mmis contract developments ; however , our estimate of the financial statement impact is subject to change once the matter is settled with the state of new york . as a result of the significant impact of the ny mmis charge on our reported revenues , earnings and key metrics for the period , we also discuss our results excluding the impact of these charges . these adjusted results are noted as “ adjusted ” in the discussion below . refer to the “ non-gaap financial measures ” section for a reconciliation and explanation of these non-gaap financial measures . significant 2015 charges health enterprise charge late in the third quarter of 2015 , we determined that we would not fully complete the health enterprise medicaid platform implementation projects in california and montana . however , we would continue to process medicaid claims using existing legacy systems in those states , thus providing uninterrupted service for the states ' healthcare providers and constituents . conduent inc. 2016 annual report 25 this determination resulted in recording a pre-tax charge ( he charge ) of $ 389 million ( $ 237 million after-tax ) in 2015. the charge included $ 116 million for the write-off of contract receivables ( primarily non-current ) , $ 34 million related to the non-cash impairment of the he software and deferred contract set-up transition costs and $ 23 million for other related assets and liabilities . the remainder of the charge was primarily related to settlement costs including payments to subcontractors resulting in cash outflows in future quarters . of the $ 389 million charge , $ 116 million was recorded as a reduction to revenues and the remaining $ 273 million was recorded to cost of outsourcing . this development followed the government healthcare strategy change announced in july 2015 , regarding our decision to focus our future he implementations on current medicaid customers and to discontinue investment in and sales of the xerox integrated eligibility system . this change in strategy resulted in pre-tax non-cash software platform impairment charges of $ 146 million ( $ 89 million after-tax ) in the second quarter 2015. as a result of the significant impact of the he charge and the software impairment charges on our reported revenues , earnings and key metrics for the period , we are also discussing our results excluding the impact of these charges . these adjusted results are noted as “ adjusted ” in the discussion below . refer to the `` non-gaap financial measures `` section for a reconciliation and explanation of these non-gaap financial measures . divestitures in december 2014 , we announced an agreement to sell our information technology outsourcing ( ito ) business to atos se and began reporting it as a discontinued operation . the sale was completed on june 30 , 2015. refer to note 4 - divestitures in our consolidated financial statements for additional information . financial overview total revenues of $ 6.4 billion for the year ended december 31 , 2016 , decreased 4 % , with a 1-percentage point negative impact from currency , as compared to 2015. on an adjusted 1 basis , excluding the ny mmis charge , total revenues decreased 4 % with a 1-percentage point negative impact from currency , resulting from declines in commercial industries and healthcare . story_separator_special_tag these valuation approaches require significant judgment and consider a number of factors that include , but are not limited to , expected future cash flows , growth rates and discount rates and comparable multiples from publicly traded companies in our industry . in addition , we are required to make certain assumptions and estimates regarding the current economic environment , industry factors and the future profitability of our businesses . when performing our discounted cash flow analysis for each reporting unit , we incorporate the use of projected financial information and discount rates that are developed using market participant-based assumptions . the cash-flow projections are based on three-year financial forecasts developed by management that include revenue and expense projections , restructuring and strategic transformation activities , capital spending trends and investment in working capital to support anticipated revenue growth or other changes in the business . the selected discount rates consider the risk and nature of the respective reporting units ' cash flows , appropriate capital structure and rates of return that market participants would require to invest their capital in our reporting units . we believe these assumptions are appropriate and reflect our forecasted long-term business model and give appropriate consideration to our historical results as well as the current economic environment and markets that we serve . the average discount rate applied to our projected cash flows for our commercial industries reporting unit was approximately 16 % and 9.5 % was used for both the public sector and healthcare reporting units , which we considered reasonable based on the estimated capital costs of applicable market participants . our impairment assessment methodology includes the use of outside valuation experts and the inclusion of factors and assumptions related to third-party market participants . when performing our market approach for each reporting unit , we rely specifically on the guideline public company method . our guideline public company method incorporates revenues and earnings multiples from publicly traded companies with operations and other characteristics similar to each reporting unit . the selected multiples consider each reporting unit 's relative growth , profitability , size and risk relative to the selected publicly traded companies . after completing our annual impairment review for each reporting unit in the fourth quarter of 2016 , based on our quantitative assessments , we concluded that the fair value of our commercial industries reporting unit was less than its carrying value by approximately 53 % , indicating an impairment . accordingly , we preformed the next step based on step 2 of the impairment assessment process , which resulted in our recording a pre-tax goodwill impairment charge of $ 935 during the fourth quarter of 2016 , which is separately presented in the consolidated statements of income ( loss ) . our healthcare and public sector reporting units passed step 1 of the impairment test with fair value exceeded carrying value by approximately 19 % and 14 % , respectively . refer to note 7 - goodwill and intangible assets , net in the consolidated financial statements for additional information regarding goodwill by reportable segment and the 2016 goodwill impairment charge . conduent inc. 2016 annual report 30 restructuring and asset impairments we have engaged in restructuring actions , which require management to estimate the timing and amount of severance and other employee separation costs for workforce reduction , the fair value of assets made redundant or obsolete and the fair value of lease cancellation and other exit costs . we accrue for severance and other employee separation costs under these actions when it is probable that benefits will be paid and the amount is reasonably estimable . the rates used in determining severance accruals are based on existing plans , historical experiences and negotiated settlements . for a full description of our restructuring actions , refer to our discussions of restructuring in the md & a and in note 8—restructuring programs and asset impairment charges in the consolidated financial statements . income taxes we are subject to income taxes in the united states and numerous foreign jurisdictions . the determination of our provision for income taxes requires significant judgment , the use of estimates and the interpretation and application of complex tax laws . our provision is based on nonrecurring events as well as recurring factors , including the taxation of foreign income . in addition , our provision will change based on discrete or other nonrecurring events such as audit settlements , tax law changes , changes in valuation allowances , and etc . , that may not be predictable . in the event that there is a significant unusual or one-time item recognized in our operating results , the taxes attributable to that item would be separately calculated and recorded at the same time as an unusual or one-time item . we record the estimated future tax effects of temporary differences between the tax bases of assets and liabilities and amounts reported in our consolidated balance sheets , as well as operating loss and tax credit carryforwards . we follow very specific and detailed guidelines in each tax jurisdiction regarding the recoverability of any tax assets recorded in our consolidated balance sheets and provide valuation allowances as required . we regularly review our deferred tax assets for recoverability considering historical profitability , projected future taxable income , the expected timing of the reversals of existing temporary differences and tax planning strategies . gross deferred tax assets of $ 360 million and $ 414 million had valuation allowances of $ 24 million and $ 38 million at december 31 , 2016 and 2015 , respectively . we are subject to ongoing tax examinations and assessments in various jurisdictions . accordingly , we may incur additional tax expense based upon our assessment of the more-likely-than-not outcomes of such matters . in addition , when applicable , we adjust previously recorded tax expense to reflect examination results . our ongoing assessments of the more-likely-than-not outcomes of examinations and

